SafeSanté obtains a commitment of 12 million euros from the GEM group to democratize its IoT telemedicine solutions and create a virtual EU medical center

Under the terms of the agreement, GEM undertakes to provide SafeSanté with a share subscription facility of up to € 12 million for a period of 36 months after the initial public offering of the company’s shares on a European national scholarship. SafeSanté will control the timing and maximum amount of withdrawal under the facility and has no minimum withdrawal obligation. Along with the public listing of SafeSanté shares, GEM will receive warrants to purchase shares of the company.

Subject to the availability of funding, the proceeds will be used to further develop its telemedicine offering by France and in Europe with the aim of improving access to healthcare and reducing barriers. SafeSanté’s telemedicine solutions are aimed at all healthcare professionals, healthcare establishments and patients. It incorporates revolutionary medical devices that allow physicians to examine patients remotely as well as face to face, for general or specialized medicine. “We are very happy with GEM’s commitment and welcome them to this adventure of improving access to healthcare. mentionned Yonathan Abbou, PhD, founder and active president of SafeSanté. “This funding and the fact of becoming a public entity will help us to expand our activities in France and in Europe in several domains. Our vision is to connect patients and healthcare professionals through our digital tools and Hi-Tech connected devices. Our goal is to build the largest virtual medical center in the Europe in order to give every patient the chance to quickly access quality care. “

About SafeSanté:

SafeSanté was founded in Paris in 2014 by Yonathan Abbou, PhD and aims to connect patients and physicians with the best technological tools at our disposal. SafeSanté Doc is already used by many doctors in France who follow their patients remotely. SafeSanté has also integrated telemedicine terminals with connected medical devices in pharmacies, health establishments or mobile devices for liberal nurses.

About the GEM Group:

Global Emerging Markets (GEM) is a $ 3.4 billion alternative investment group based in Paris, New York and Los Angeles. GEM manages a diverse set of investment vehicles focused on emerging markets and has completed 400 transactions in 70 countries. Each investment vehicle has different sets of operational concepts of risk, adjusted return and liquidity profile. The family of funds and investment vehicles provides GEM and its partners with exposure to: buyouts of small and mid-capitalization companies, private investments in public stocks and certain venture capital investments. For more information :

Contact: +33 (0), [email protected]

Photo –

Logo –

SOURCE SafeSanté

Previous Vaccine supply in New Hampshire exceeds demand, active cases continue to decline
Next FTSE 100 lags as traders reflect on UK economic recovery